Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10393)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang XY, Zheng ZX, Sun Y, Bai YH, Shi YF, Zhou LX, Yao YF, Wu AW, Cao DF. Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas. World J Gastrointest Oncol 2019; 11(4): 335-347 [PMID: 31040898 DOI: 10.4251/wjgo.v11.i4.335] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i4/335.htm |
| Number | Citing Articles |
| 1 |
Jiahao Han, Xiangyu Wang, Chong Zhang, Qian Wu, Xiaochen Ma, Yitong Li, Zhenmei Chen, Rui Zhang, Guo Zhang, Jing Lin, Lu Lu, Wenwei Zhu, Huliang Jia, Jubo Zhang, Jie Fan, Jinhong Chen. Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases. Journal of Surgical Oncology 2022; 125(6): 991 doi: 10.1002/jso.26815
|
| 2 |
Oscar Hernandez Dominguez, Sumeyye Yilmaz, Scott R. Steele. Stage IV Colorectal Cancer Management and Treatment. Journal of Clinical Medicine 2023; 12(5): 2072 doi: 10.3390/jcm12052072
|
| 3 |
Anshoo Agarwal, Abdulmajed Mohammad AlRawaili, Mohammed Khalid AlZalbani, Ghadah Khalid AlAnazi, Shahad Khalaf AlAnazi, Shahad Aqeel Daham AlEnezi. Immune-Markers in GallBladder Lesions and their Clinico-Diagnostic and Prognostic Significance - An Overview. International Journal of Pharmaceutical Research And Allied Sciences 2023; 12(1): 47 doi: 10.51847/NBEs0VKQMp
|
| 4 |
Ritu Jangir, Ajay Sharma, Anjali Sharma, Rateesh Sareen. STUDY OF HER2 NEU POSITIVITY IN GASTROINTESTINAL CANCERS AT A TERTIARY CARE HOSPITAL IN INDIA. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 7 doi: 10.36106/ijsr/7517525
|
| 5 |
Nana Lyu, Bernadette Pedersen, Elena Shklovskaya, Helen Rizos, Mark P. Molloy, Yuling Wang. SERS characterization of colorectal cancer cell surface markers upon anti‐EGFR treatment. Exploration 2022; 2(3) doi: 10.1002/EXP.20210176
|
| 6 |
Divya Khosla, Aditya Kumar Singla, Rahul Gupta, Rakesh Kapoor. Molecular Biomarkers for Cancer Diagnosis and Therapy. 2024; : 457 doi: 10.1007/978-981-99-3746-2_22
|
| 7 |
Ali Azadi, Alireza Golchini, Sina Delazar, Fatemeh Abarghooi Kahaki, Seyed Mohsen Dehnavi, Zahra Payandeh, Shirin Eyvazi. Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines. Biological Procedures Online 2021; 23(1) doi: 10.1186/s12575-021-00147-7
|
| 8 |
Zehua Wu, Yi Cheng, Huaiming Wang, Dian Liu, Xiaoxing Qi, Chao Wang, Yuanzhe Zhang, Yuting Zhang, Runkai Cai, Hong Huo, Jianwei Zhang, Yue Cai, Weiwei Li, Huabin Hu, Yanhong Deng. Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer. Cancers 2023; 15(2): 554 doi: 10.3390/cancers15020554
|
| 9 |
Zhouhuan Dong, Linghong Kong, Zhiyi Wan, Fengwei Zhu, Mei Zhong, Yali Lv, Po Zhao, Huaiyin Shi. Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53039-y
|
| 10 |
Arndt Stahler, Andreas J. Kind, Christine Sers, Soulafa Mamlouk, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Stefan Kasper, Beeke Hoppe, Annika Kurreck, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stintzing, Tanja Trarbach, Dominik P. Modest. Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical Cancer Research 2024; 30(7): 1256 doi: 10.1158/1078-0432.CCR-23-3023
|
| 11 |
Kyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee, Sukmook Lee. Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers. Biomedicines 2021; 9(1): 39 doi: 10.3390/biomedicines9010039
|
| 12 |
Barbara Brunetti, Barbara Bacci, Giuseppe Sarli, Elisa Pancioni, Luisa Vera Muscatello. Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study. Animals 2021; 11(4): 1006 doi: 10.3390/ani11041006
|
| 13 |
Eman A. Abdul Razzaq, Thenmozhi Venkatachalam, Khuloud Bajbouj, Mohamed Rahmani, Amena Mahdami, Surendra Rawat, Naziha Mansuri, Hussein Alhashemi, Rifat Akram Hamoudi, Riyad Bendardaf. HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients. Libyan Journal of Medicine 2021; 16(1) doi: 10.1080/19932820.2021.1955462
|
| 14 |
K. A. Oganyan, A. A. Musaelyan, M. A. Kotikova, S. V. Lapin, V. D. Nazarov, M. A. Belyaev, A. A. Zakharenko, S. V. Orlov. Molecular genetic characteristics of colorectal cancer depending on the status of microsatellite instability. Meditsinskiy sovet = Medical Council 2022; (9): 139 doi: 10.21518/2079-701X-2022-16-9-139-146
|
| 15 |
A. Babkoff, A. Zick, A. Hubert, P. Tarantino, A. Grinshpun. Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future. ESMO Gastrointestinal Oncology 2024; 3: 100032 doi: 10.1016/j.esmogo.2023.100032
|
| 16 |
Tongbram Malemnganbi Chanu, Lakhon Kma, R. N. Sharan. Cancer Biomarkers: Status and Its Future Direction. Indian Journal of Surgery 2023; 85(6): 1323 doi: 10.1007/s12262-023-03723-1
|
| 17 |
Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran, Xiaoming Xing. HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China. PeerJ 2020; 8: e8602 doi: 10.7717/peerj.8602
|
| 18 |
Alessandra Anna Prete, Valentina Angerilli, Francesca Bergamo, Valentina Vettore, Chiara De Toni, Rossana Intini, Krisida Cerma, Gianmarco Ricagno, Riccardo Cerantola, Eleonora Perissinotto, Antonio De Rosa, Carlotta Ceccon, Jessica Gasparello, Luca Denaro, Alberto D’Amico, Franco Chioffi, Elena Carcea, Matteo Fassan, Sara Lonardi. HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study. British Journal of Cancer 2024; 130(8): 1316 doi: 10.1038/s41416-023-02569-4
|
| 19 |
Santu Sarkar, Sezgin Kiren, William H. Gmeiner. Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs. Pharmaceutics 2024; 16(6): 734 doi: 10.3390/pharmaceutics16060734
|
| 20 |
Li-Feng Hu, Huan-Rong Lan, Dong Huang, Xue-Min Li, Ke-Tao Jin. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.769305
|
| 21 |
Hisateru Yasui, Atsushi Takeno, Hiroki Hara, Hiroshi Imamura, Hiroki Akamatsu, Kazumasa Fujitani, Minoru Nakane, Chihiro Nakayama Kondoh, Seigo Yukisawa, Junichiro Nasu, Yoshinori Miyata, Akitaka Makiyama, Hiroyasu Ishida, Norimasa Yoshida, Eiji Matsumura, Masato Ishigami, Masahiro Sugihara, Atsushi Ochiai, Toshihiko Doi. Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study. International Journal of Colorectal Disease 2022; 37(6): 1393 doi: 10.1007/s00384-022-04162-2
|
| 22 |
Ke-Tao Jin, Bo Chen, Yu-Yao Liu, H uan-Rong Lan, Jie-Ping Yan. Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01763-9
|
| 23 |
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082
|
| 24 |
Izabela Siemińska, Kazimierz Węglarczyk, Marta Walczak, Agata Czerwińska, Radosław Pach, Mateusz Rubinkiewicz, Antoni Szczepanik, Maciej Siedlar, Jarek Baran. Mo-MDSCs are pivotal players in colorectal cancer and may be associated with tumor recurrence after surgery. Translational Oncology 2022; 17: 101346 doi: 10.1016/j.tranon.2022.101346
|
| 25 |
Shujuan Ni, Xin Wang, Jinjia Chang, Hui Sun, Weiwei Weng, Xu Wang, Cong Tan, Meng Zhang, Lei Wang, Zhaohui Huang, Dan Huang, Midie Xu, Weiqi Sheng. Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.842787
|
| 26 |
Taylor Smith, Kevin Affram, Ebony L. Nottingham, Bo Han, Felix Amissah, Sunil Krishnan, Jose Trevino, Edward Agyare. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73218-6
|
| 27 |
Stanislav John. Current perspective on the treatment of advanced/metastatic colorectal cancer. Onkologie 2020; 14(3): 126 doi: 10.36290/xon.2020.025
|
| 28 |
Liu Yang, Wenfei Li, Zhihao Lu, Ming Lu, Jun Zhou, Zhi Peng, Xiaotian Zhang, Xicheng Wang, Lin Shen, Jian Li. Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09447-x
|
| 29 |
Susnata Khan, Senjuti Dasgupta, Asit Ranjan Deb. Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study. South Asian Journal of Cancer 2024; doi: 10.1055/s-0044-1789276
|